Delivery Order SPE2DB22D1106-SPE2DB25FFDD5
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency (DLA) for CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $5,794.03. This non-competitive delivery order is structured as a firm fixed-price contract with an ultimate completion date of August 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) with a contract ceiling value of $7,558.14. The order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $3,351.92 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $9,165.94. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $9,468.39 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of CAPLYTA 21 mg capsules (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CAPLYTA 10.5 mg capsules (30-count units) valued at $37,624.77 on June 26, 2025, with completion scheduled for June 27, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The contract requires...
- The Defense Logistics Agency awarded a $1,278.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement with no set-aside designation. The delivery order has an ultimate completion date of July 23, 2025, with performance at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) valued at $3,348.66 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,060.57 for 30-count bottles of CAPLYTA 42 mg capsules, an atypical antipsychotic medication. The contract, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, was competitively awarded without set-aside restrictions through a Firm Fixed Price delivery order structure. The Defense Logistics Agency, operating under the Department of Defense, is the funding...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDD5Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 13, 2025, by the Defense Logistics Agency (DLA) for CAPLYTA 42 mg capsules (30-count supply). This firm fixed-price delivery order, valued at $79,678.43, represents a non-competitive set-aside award and is scheduled for completion by August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CAPLYTA is a pharmaceutical product used in psychiatric care, reflecting the federal government's ongoing medical procurement needs through the DLA's supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military and federal healthcare systems worldwide. AmerisourceBergen's selection reflects its demonstrated capability to meet federal procurement requirements and deliver critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $79.7k | 8/13/25 |